Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 118,900 | 109,700 | 78,800 | N/A | 8,900 |
| Depreciation Amortization | 39,300 | 26,300 | 13,200 | N/A | 35,000 |
| Income taxes - deferred | -24,900 | -25,900 | 4,700 | N/A | 2,000 |
| Accounts receivable | -14,400 | -13,000 | -6,200 | N/A | -40,300 |
| Accounts payable and accrued liabilities | -2,000 | 3,000 | 400 | N/A | 2,000 |
| Other Working Capital | -6,100 | -15,100 | -13,100 | N/A | -33,100 |
| Other Operating Activity | -42,800 | -28,500 | -54,300 | 0 | 95,100 |
| Operating Cash Flow | $68,000 | $56,500 | $23,500 | $N/A | $69,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,600 | -3,700 | -1,600 | N/A | -5,400 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -216,100 |
| Purchase Of Investment | -79,400 | -61,300 | -31,500 | N/A | -74,600 |
| Sale Of Investment | 65,500 | 45,200 | 17,900 | N/A | 145,500 |
| Investing Cash Flow | $-20,500 | $-19,800 | $-15,200 | $N/A | $-150,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 199,000 |
| Debt Issued | 53,000 | N/A | 0 | N/A | 204,000 |
| Debt Repayment | -83,000 | -56,000 | -25,000 | N/A | -37,000 |
| Common Stock Issued | 18,200 | 6,300 | 1,700 | N/A | 1,300 |
| Common Stock Repurchased | 0 | N/A | N/A | N/A | -31,600 |
| Other Financing Activity | -41,900 | 300 | 0 | 0 | -200,600 |
| Financing Cash Flow | $-53,700 | $-49,400 | $-23,300 | $N/A | $135,100 |
| Exchange Rate Effect | 1,200 | -1,000 | 500 | N/A | 1,200 |
| Beginning Cash Position | 102,400 | 102,400 | 102,400 | N/A | 68,500 |
| End Cash Position | 97,400 | 88,700 | 87,900 | N/A | 123,800 |
| Net Cash Flow | $-5,000 | $-13,700 | $-14,500 | $N/A | $55,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 68,000 | 56,500 | 23,500 | N/A | 69,600 |
| Capital Expenditure | -6,600 | -3,700 | -1,600 | N/A | -5,400 |
| Free Cash Flow | 61,400 | 52,800 | 21,900 | 0 | 64,200 |